Old Web
English
Sign In
Acemap
>
Paper
>
PRO79 EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN
PRO79 EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN
2019
F.J. Badia
J. L. Poveda
M. Tort
V Tania
J. Shepherd
Keywords:
Reimbursement
Medicine
Orphan drug
Intensive care medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]